Last reviewed · How we verify
Erythema nodosum leprosum
Approved treatments
- Thalomid · Ann & Robert H Lurie Children's Hospital of Chicago
- Thalomid · Bristol-Myers Squibb
Thalomid works by inhibiting the production of tumor necrosis factor, a protein that promotes inflammation and tumor growth. - Lamprene · Novartis
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Erythema nodosum leprosum patent landscape — cliff calendar, originator estates, attackable patents
- Erythema nodosum leprosum treatment landscape brief
- Erythema nodosum leprosum treatment updates RSS
Frequently asked questions about Erythema nodosum leprosum
What drugs treat Erythema nodosum leprosum?
Tracked treatments include Thalomid, Lamprene.
What is the treatment for Erythema nodosum leprosum?
Standard treatment for Erythema nodosum leprosum includes Thalomid, Lamprene. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Erythema nodosum leprosum patent cliff · Erythema nodosum leprosum CI report
- Treatment: Thalomid · Ann & Robert H Lurie Children's Hospital of Chicago
- Treatment: Thalomid · Bristol-Myers Squibb
- Treatment: Lamprene · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing